Restrictive prescription of antibiotics in preterm infants with premature rupture of membranes
- PMID: 35820876
- PMCID: PMC9275236
- DOI: 10.1186/s12887-022-03476-y
Restrictive prescription of antibiotics in preterm infants with premature rupture of membranes
Abstract
Background: In preterm infants with premature rupture of membranes, antibiotic treatment is frequently started but rates of early onset sepsis are lower. In line with national guidelines, a stratified approach in the decision to start antibiotic treatment using maternal history, clinical impression and biomarkers has been implemented in our level III neonatal center and its results are evaluated.
Methods: Retrospective cohort study of all preterm newborns with rupture of membranes at least 1 h prior to delivery admitted to our tertiary neonatal intensive care unit. Data on antibiotic exposure, mortality and major neonatal complications were extracted from the electronic patient charts to evaluate the effects and safety of our stratified approach.
Results: Four hundred fifty-six infants met the inclusion criteria. 120 (26%) received primary antibiotics whereas 336 (74%) did not. Of those receiving primary antibiotics, 13 (11%) had a blood culture positive sepsis, 46 (38%) met the criteria of clinical sepsis and in 61 (51%) sepsis was ruled out and antibiotics were stopped after 48-96 h. All infants with blood culture positive sepsis were identified and treated within the first 24 h of life using this approach. None of the 336 infants who were not started on antibiotics primarily needed antibiotic therapy within the first 5 days of life. There were no deaths or major neonatal complications in the group that did not receive empiric antibiotics.
Conclusions: Our stratified approach for preterm infants with premature rupture of membranes allows a safe reduction of antibiotic exposure even in this high risk population. As a result, only 25% of high risk preterm newborns are treated with antibiotics of which more than half receive less than 5 days of treatment. To treat one infant with blood culture positive sepsis, only 9 infants receive empiric antibiotics.
Keywords: Antibiotic stewardship; Early onset sepsis; PPROM.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
The NICU Antibiotics and Outcomes (NANO) trial: a randomized multicenter clinical trial assessing empiric antibiotics and clinical outcomes in newborn preterm infants.Trials. 2022 May 23;23(1):428. doi: 10.1186/s13063-022-06352-3. Trials. 2022. PMID: 35606829 Free PMC article. Clinical Trial.
-
Implementation of a 24-hour empiric antibiotic duration for negative early-onset sepsis evaluations to reduce early antibiotic exposure in premature infants.Infect Control Hosp Epidemiol. 2023 Aug;44(8):1308-1313. doi: 10.1017/ice.2022.246. Epub 2022 Oct 24. Infect Control Hosp Epidemiol. 2023. PMID: 36278513
-
Clinical and Microbiologic Characteristics of Early-onset Sepsis Among Very Low Birth Weight Infants: Opportunities for Antibiotic Stewardship.Pediatr Infect Dis J. 2017 May;36(5):477-481. doi: 10.1097/INF.0000000000001473. Pediatr Infect Dis J. 2017. PMID: 28403049 Free PMC article.
-
Antibiotic use and misuse in the neonatal intensive care unit.Clin Perinatol. 2012 Mar;39(1):61-8. doi: 10.1016/j.clp.2011.12.003. Epub 2011 Dec 29. Clin Perinatol. 2012. PMID: 22341537 Free PMC article. Review.
-
Preterm premature rupture of the membranes: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF).Eur J Obstet Gynecol Reprod Biol. 2019 May;236:1-6. doi: 10.1016/j.ejogrb.2019.02.021. Epub 2019 Mar 2. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 30870741 Review.
References
-
- Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51(RR-11):1–22. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous